Continuous Glucose Monitoring: CGM HealthTech sub market matures in 2025 with more impact and evidence

Continuous Glucose Monitoring – where is the evidence for CGM?

The continuous glucose monitoring (CGM) healthtech submarket is driven by a combination of clinical evidence, market growth data, and technological advancements, primarily for diabetes management but increasingly for broader health applications. Below is a breakdown of the evidence supporting the CGM market, drawn from clinical studies, market analyses, and emerging trends, with a critical examination of the data.

1. Clinical Evidence for CGM in Diabetes Management

CGM devices provide real-time glucose readings, improving glycemic control compared to traditional self-monitoring blood glucose (SMBG) methods. Key evidence includes:

• Improved Glycemic Control: Studies demonstrate CGM reduces HbA1c levels (a marker of long-term glucose...

Today's Sponsors

Today's Sponsor